BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33033896)

  • 1. The correlation between circulating inflammatory, oxidative stress, and neurotrophic factors level with the cognitive outcomes in multiple sclerosis patients.
    Talebi M; Majdi A; Nasiri E; Naseri A; Sadigh-Eteghad S
    Neurol Sci; 2021 Jun; 42(6):2291-2300. PubMed ID: 33033896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cambridge Neuropsychological Test Automated Battery (CANTAB) Versus the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) for the Assessment of Cognitive Function in Patients with Multiple Sclerosis.
    Talebi M; Majdi A; Kamari F; Sadigh-Eteghad S
    Mult Scler Relat Disord; 2020 Aug; 43():102172. PubMed ID: 32442887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The subtleties of cognitive decline in multiple sclerosis: an exploratory study using hierarchichal cluster analysis of CANTAB results.
    Cabeça HLS; Rocha LC; Sabbá AF; Tomás AM; Bento-Torres NVO; Anthony DC; Diniz CWP
    BMC Neurol; 2018 Sep; 18(1):140. PubMed ID: 30200902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients.
    Naseri A; Forghani N; Sadigh-Eteghad S; Shanehbandi D; Asadi M; Nasiri E; Talebi M
    Mult Scler Relat Disord; 2022 Jan; 57():103432. PubMed ID: 34922253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Web-Based and Lab-Based Cognitive Assessment Using the Cambridge Neuropsychological Test Automated Battery: A Within-Subjects Counterbalanced Study.
    Backx R; Skirrow C; Dente P; Barnett JH; Cormack FK
    J Med Internet Res; 2020 Aug; 22(8):e16792. PubMed ID: 32749999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive Pattern of Cognitive Disorders During Multiple Sclerosis Relapse and Recovery Based on Computerized CANTAB Tests.
    Giedraitiene N; Kaubrys G
    Front Neurol; 2019; 10():572. PubMed ID: 31214108
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between vitamin D levels and cognitive impairment in patients with multiple sclerosis.
    Alhussain F; Alomar M; Alenazi A; Aldraihem M; Alshiha L; Bashir S
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):2021-2030. PubMed ID: 33660814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effects of high-education levels on cognition in different stages of multiple sclerosis.
    Rimkus CM; Avolio IMB; Miotto EC; Pereira SA; Mendes MF; Callegaro D; Leite CDC
    Mult Scler Relat Disord; 2018 May; 22():41-48. PubMed ID: 29554549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
    Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
    BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment.
    Cacciamani F; Salvadori N; Eusebi P; Lisetti V; Luchetti E; Calabresi P; Parnetti L
    Appl Neuropsychol Adult; 2018; 25(3):237-248. PubMed ID: 28631988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care.
    Cotter J; Vithanage N; Colville S; Lyle D; Cranley D; Cormack F; Barnett JH; Murray K; Pal S
    Front Neurol; 2018; 9():331. PubMed ID: 29867739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
    Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
    J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of oxidative stress on cognitive impairment in first episode schizophrenia].
    Wang YP; Zhang PF; Yuan XX; Liu YF; Li HH; Tao Q; Li X; Pang LJ; Song XQ
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(1):9-13. PubMed ID: 30641657
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum levels of glial cell line-derived neurotrophic factor and multiple neurotransmitters: In relation to cognitive performance in Parkinson's disease with mild cognitive impairment.
    Liu Y; Tong S; Ding L; Liu N; Gao D
    Int J Geriatr Psychiatry; 2020 Feb; 35(2):153-162. PubMed ID: 31650626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High BDNF serum levels are associated to good cognitive functioning in bipolar disorder.
    Mora E; Portella MJ; Piñol-Ripoll G; López R; Cuadras D; Forcada I; Teres M; Vieta E; Mur M
    Eur Psychiatry; 2019 Aug; 60():97-107. PubMed ID: 30808582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
    Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.
    Bora E
    Psychol Med; 2019 Sep; 49(12):1971-1979. PubMed ID: 31284882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of socio-demographic variables on performance on the Cambridge neuropsychological automated tests for the assessment of dementia and Portuguese norms for older adults living in retirement homes.
    Matos Gonçalves M; Pinho MS; Rodrigues Simões M
    Clin Neuropsychol; 2016 Feb; 30(2):284-317. PubMed ID: 26956931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Ability of Some CANTAB Battery Test Measures to Detect Cognitive Response to a Single Dose of Donepezil in Alzheimer Disease.
    Kuzmickienė J; Kaubrys G
    Med Sci Monit; 2015 Aug; 21():2572-82. PubMed ID: 26336931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial.
    Lees J; Michalopoulou PG; Lewis SW; Preston S; Bamford C; Collier T; Kalpakidou A; Wykes T; Emsley R; Pandina G; Kapur S; Drake RJ
    Psychol Med; 2017 Oct; 47(13):2358-2368. PubMed ID: 28464963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.